1. Home/
  2. Compounds/
  3. selumetinib:navitoclax (8:1 mol/mol)

selumetinib:navitoclax (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:navitoclax (8:1 mol/mol)
PharmacoGx selumetinib:navitoclax (8:1 mol/mol)

Cell lines tested with selumetinib:navitoclax (8:1 mol/mol)

802 cell lines have been tested with this compound, using data from 1 dataset(s).
A549 lung CTRPv23
DU-145 prostate CTRPv22
AsPC-1 pancreas CTRPv22
NCI-H1869 lung CTRPv22
CCF-STTG1 central nervous system CTRPv22
OAW-28 ovary CTRPv22
HeLa cervix CTRPv22
LOXIMVI haematopoietic and lymphoid tissue CTRPv22
NCI-H520 lung CTRPv22
MKN74 stomach CTRPv22
Download CSV

Tissues tested with selumetinib:navitoclax (8:1 mol/mol)

25 tissues have been tested with this compound, using data from 1 dataset(s).
lungCTRPv2139
haematopoietic and lymphoid tissueCTRPv2136
N/ACTRPv247
large intestineCTRPv246
central nervous systemCTRPv245
skinCTRPv243
ovaryCTRPv241
pancreasCTRPv240
breastCTRPv240
stomachCTRPv232
Download CSV
Download Data as CSV

Top molecular features associated with response to selumetinib:navitoclax (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ETV6 CTRPv2 AAC 0.28 2e-13
mRNA NRROS CTRPv2 AAC 0.34 4e-13
mRNA IRF2BP2 CTRPv2 AAC 0.26 4e-12
mRNA GRAMD4 CTRPv2 AAC 0.26 4e-11
mRNA ZFP36L2 CTRPv2 AAC 0.26 4e-11
mRNA C16orf87 CTRPv2 AAC -0.23 6e-10
mRNA ASB3 CTRPv2 AAC -0.23 9e-10
mRNA LGALS9 CTRPv2 AAC 0.24 1e-09
mRNA PRPS1 CTRPv2 AAC -0.23 1e-09
mRNA TSNARE1 CTRPv2 AAC 0.22 2e-09
Download CSV